BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 30248975)

  • 1. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.
    Marrugo-Ramírez J; Mir M; Samitier J
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer.
    Sierra J; Marrugo-Ramirez J; Rodríguez-Trujillo R; Mir M; Samitier J
    Sensors (Basel); 2020 Feb; 20(5):. PubMed ID: 32121271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
    Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
    Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A headlight on liquid biopsies: a challenging tool for breast cancer management.
    Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A
    Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
    Muinelo-Romay L; Casas-Arozamena C; Abal M
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress on liquid biopsy in oncology and its clinical applications.
    Wang C; Li YM; Fang XD
    Yi Chuan; 2017 Mar; 39(3):220-231. PubMed ID: 28420618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case.
    Appierto V; Di Cosimo S; Reduzzi C; Pala V; Cappelletti V; Daidone MG
    Semin Cancer Biol; 2017 Jun; 44():106-116. PubMed ID: 28442298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of emerging liquid biomarkers in advanced prostate cancer.
    Vandekerkhove G; Chi KN; Wyatt AW
    Cancer Genet; 2018 Dec; 228-229():151-158. PubMed ID: 28958406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.
    Kamińska P; Buszka K; Zabel M; Nowicki M; Alix-Panabières C; Budna-Tukan J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J; Liu R; Huang C; Chen S; Xu M
    Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of circulating biomarkers in liquid biopsy diagnostics.
    Yeo JC; Lim CT
    Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.